0.00
Schlusskurs vom Vortag:
$2.27
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$227.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-299.80M
KGV:
0.00
EPS:
-2.84
Netto-Cashflow:
$-217.49M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
Acelyrin Inc Stock (SLRN) Company Profile
Firmenname
Acelyrin Inc
Sektor
Branche
Telefon
805-456-4393
Adresse
4149 LIBERTY CANYON RD., AGOURA HILLS
Vergleichen Sie SLRN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SLRN
Acelyrin Inc
|
0.00 | 227.15M | 0 | -299.80M | -217.49M | -2.84 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Acelyrin Inc Stock (SLRN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-07-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-12-13 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-08 | Eingeleitet | Citigroup | Neutral |
2023-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2023-09-05 | Eingeleitet | H.C. Wainwright | Buy |
2023-05-30 | Eingeleitet | Jefferies | Buy |
2023-05-30 | Eingeleitet | Morgan Stanley | Overweight |
2023-05-30 | Eingeleitet | Piper Sandler | Overweight |
2023-05-30 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Acelyrin Inc Aktie (SLRN) Neueste Nachrichten
Analyzing net buyer seller activity in Acelyrin Inc.Market Rally & Smart Money Movement Tracker - Newser
Short interest data insights for Acelyrin Inc.Take Profit & Long-Term Capital Growth Strategies - Newser
Is Acelyrin Inc. stock ready for a breakoutPortfolio Value Summary & Weekly Stock Breakout Alerts - Newser
Published on: 2025-08-31 00:19:58 - Newser
Is now a turning point for Acelyrin Inc.Exit Point & Pattern Based Trade Signal System - Newser
What’s the recovery path for long term holders of Acelyrin Inc. - Newser
Real time breakdown of Acelyrin Inc. stock performance2025 Momentum Check & Daily Stock Momentum Reports - Newser
How sentiment analysis helps forecast Acelyrin Inc.Quarterly Growth Report & Technical Buy Zone Confirmations - Newser
Published on: 2025-08-30 22:20:03 - Newser
Ranking Acelyrin Inc. among high performing stocks via toolsJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Chart based exit strategy for Acelyrin Inc.July 2025 Update & Accurate Intraday Trading Signals - Newser
What data driven models say about Acelyrin Inc.’s futureWeekly Trading Summary & Community Driven Trade Alerts - Newser
Is Acelyrin Inc. still worth holding after the dipJuly 2025 Update & Fast Gain Swing Alerts - Newser
Visual trend scoring systems applied to Acelyrin Inc.July 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
How institutional ownership impacts Acelyrin Inc. stock2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Leading vs lagging indicators on Acelyrin Inc. performanceMarket Growth Summary & Stock Portfolio Risk Control - Newser
Signal strength of Acelyrin Inc. stock in tech scannersVolume Spike & Free Daily Entry Point Trade Alerts - Newser
Custom Dashboard Highlights Acelyrin Inc. Price Momentum getLinesFromResByArray error: size == 0 - thegnnews.com
Is Acelyrin Inc. a good ESG investmentShare Buyback & Consistent Profit Alerts - sundaytimes.kr
Evaluating Acelyrin Inc. with trendline analysisWeekly Market Report & AI Powered Buy and Sell Recommendations - Newser
What’s the MACD signal for Acelyrin Inc.2025 Geopolitical Influence & Fast Gain Swing Trade Alerts - sundaytimes.kr
Can Acelyrin Inc. Regain Momentum After Breakdown2025 Major Catalysts & AI Enhanced Execution Alerts - beatles.ru
Finanzdaten der Acelyrin Inc-Aktie (SLRN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):